跳至主要内容
临床试验/NCT05453617
NCT05453617招募中不适用

Effects of Intermitting Eating on Weight-Loss Maintenance and Cardiometabolic Risk Factors in Obese Adults: A Randomized Clinical Trial

Nanfang Hospital, Southern Medical University1 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2022年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
270
试验地点
1
主要终点
Change in body weight over 12 months

研究概览

简要总结

Weight regain after weight loss is a major problem in the treatment of obesity. Two novel types of intermittent fasting recently have received more attention: the 5:2 diet and time-restricted eating (TRE). TRE requires individuals to eat in a specified number of hours per day (typically 4 to 10 hours) without energy intake restriction. The 5:2 diet involves 5 feast days and 2 fast days per week; participants eat ad libitum without restriction on feast days while 25% of energy needs (approximately 500-800 kcal per day) are consumed on fast day. This randomized controlled trial aimed to evaluate the effect of TRE and the 5:2 diet on weight loss maintenance and cardiometabolic risk factors after a low-calorie diet in obese adults over 12 months compared to usual health care.

详细描述

Weight regain after weight loss is a major problem in the treatment of persons with obesity. Two novel types of intermittent fasting recently have received more attention: the 5:2 diet and time-restricted eating (TRE). TRE requires individuals to eat in a specified number of hours per day (typically 4 to 10 hours) without energy intake restriction. The 5:2 diet involves 5 feast days and 2 fast days per week; participants eat ad libitum without restriction on feast days while 25% of energy needs (approximately 500-800 kcal per day) are consumed on fast day. Preliminary evidence suggests that both TRE and the 5:2 diet have beneficial effects on weight loss and cardioprotection in humans. Whether TRE or the 5:2 diet is an effective approach for weight-loss maintenance remains unknown. This randomized controlled trial aimed to evaluate the effect of TRE and the 5:2 diet on weight loss maintenance and cardiometabolic risk factors after a low-calorie diet in obese adults over 12 months compared to usual health care. All participants who have achieved greater than 5% of weight loss after a 8-week low-calorie-diet induced weight loss phase, will be assigned to one of the three study groups (TRE, the 5:2 diet and control groups) in a 1:1:1 ratio. Participants in the TRE group will be instructed to eat during a window of 8 h/d (8 am to 4 pm) over 12 months. Participants in the 5:2 diet group will be instructed to consume 500-600 kcal/d on fast days and eat ad libitum on feast days. Participants in the control group were instructed to receive usual health care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •1.Man or women aged 18-75 years;
  • •2.Body mass index (BMI)of 28.0 to 45.0 kg/m2;

排除标准

  • •History of HIV, hepatitis B or C (self-report) or active pulmonary tuberculosis;
  • •Diagnosis of type 1 and type 2 diabetes;
  • •History of malignant tumors;
  • •Serious liver dysfunction or chronic kidney disease (AST or ALT > 3 times the upper limit of normal, or eGFR<30 ml/min/1.73 m2);
  • •History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
  • •History of severe gastrointestinal diseases or gastrointestinal surgery in the past 12 months;
  • •History of Cushing's syndrome, hypothyroidism, acromegaly, hypothalamic obesity;
  • •Being a smoker or having been a smoker in the 3 months prior to their screening visit;
  • •Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
  • •Currently participating in weight loss programs or weight change in the past 3 months (> 5% current body weight) ;
  • •Women who are pregnant or plan to become pregnant;
  • •Patients who cannot be followed for 24 months (due to a health situation or migration);
  • •Patients who are unwilling or unable to give informed consent.

研究组 & 干预措施

The TRE group

Experimental

Participants in the TRE group will be instructed to eat during a window of 8 h/d (8 am to 4 pm).

干预措施: Time-restricted eating (Behavioral)

The 5:2 diet group

Experimental

Participants in the 5:2 diet group will be instructed to consume 500-600 kcal/d on fast days and eat ad libitum on feast days.

干预措施: The 5:2 diet (Behavioral)

Control

No Intervention

Participants in the control group will receive a general lifestyle counseling.

结局指标

主要结局

Change in body weight over 12 months

时间窗: Baseline to months 12

次要结局

  • Change in quality of sleep score measured by the Pittsburgh sleep quality index(Baseline to months 12)
  • Change in depression score measured by the Patient Health Questionnaire-9(Baseline to months 12)
  • Change in arterial stiffness measured by pulse wave velocity(Baseline to months 12)
  • Change in quality of life score measured by the 12-item Short-Form Health Survey Questionnaire(Baseline to months 12)
  • Change in body fat composition meassured by DEXA(Baseline to months 12)
  • Change in waist circumference(Baseline to months 12)
  • Change in serum LDL-c(Baseline to months 12)
  • Change in insulin sensitivity(Baseline to months 12)
  • Change in liver fat(Baseline to months 12)
  • Change in systolic blood pressure(Baseline to months 12)
  • Change in body mass index(Baseline to months 12)
  • Change in serum triglycerides(Baseline to months 12)
  • Change in serum total cholesterol(Baseline to months 12)
  • Change in HbA1c(Baseline to months 12)
  • Change in diastolic blood pressure(Baseline to months 12)
  • Change in β cell function(Baseline to months 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Huijie Zhang

Professor

Nanfang Hospital, Southern Medical University

研究点 (1)

Loading locations...

相似试验